Renaissance Technologies - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 65 filers reported holding IMMUNE DESIGN CORP in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q1 2019$6,037,000
+785.2%
1,031,905
+96.6%
0.01%
+400.0%
Q4 2018$682,000
+34.3%
524,805
+256.5%
0.00%0.0%
Q3 2018$508,000
-60.3%
147,214
+19.1%
0.00%
-50.0%
Q3 2017$1,279,000
-6.2%
123,591
-11.6%
0.00%0.0%
Q2 2017$1,363,000
+79.3%
139,800
+25.1%
0.00%
+100.0%
Q1 2017$760,000
+233.3%
111,740
+170.0%
0.00%
Q4 2016$228,000
-74.2%
41,389
-64.5%
0.00%
-100.0%
Q3 2016$883,000116,5000.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q4 2018
NameSharesValueWeighting ↓
Svennilson Peter 6,642,942$8,636,0007.61%
Versant Venture Management, LLC 2,208,210$2,870,673,0001.42%
BVF INC/IL 5,185,383$6,741,0000.88%
EcoR1 Capital, LLC 5,603,191$7,284,0000.73%
Abingworth LLP 352,300$458,0000.42%
Bain Capital Public Equity Management, LLC 892,061$1,160,0000.11%
ALGERT GLOBAL LLC 92,591$120,0000.03%
GSA CAPITAL PARTNERS LLP 41,068$53,0000.01%
OXFORD ASSET MANAGEMENT LLP 136,468$177,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 27,122$35,0000.01%
View complete list of IMMUNE DESIGN CORP shareholders